Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Bankruptcy

<< Previous

Bullboard Posts

Next >>

Comment by Quentin30on Feb 06, 2024 1:52pm

130 Views

Post# 35865732

RE:RE:RE:RE:RE:Bankruptcy

You're starting to make sense finally... yes, wait for Crispr Ther. to drop, because you know it will come back... unlike ONCY... Just look at that 6 mnth chart... or look at the 5 years chart... or the 10 year, or the full time chart..

Even if you make 10% on a swing with CRSP, it's 10% more than you had before... ONCY is going nowhere for at least another month.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing